AR001041A1 - Procedimiento para preparar clorhidrato de 1-(2'-desoxi-2'2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona - Google Patents

Procedimiento para preparar clorhidrato de 1-(2'-desoxi-2'2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona

Info

Publication number
AR001041A1
AR001041A1 AR33407495A AR33407495A AR001041A1 AR 001041 A1 AR001041 A1 AR 001041A1 AR 33407495 A AR33407495 A AR 33407495A AR 33407495 A AR33407495 A AR 33407495A AR 001041 A1 AR001041 A1 AR 001041A1
Authority
AR
Argentina
Prior art keywords
ribofuranosyl
deoxy
difluoro
hydrochloride
prepare
Prior art date
Application number
AR33407495A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23397211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR001041(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR001041A1 publication Critical patent/AR001041A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona un procedimiento para preparar clorhidrato de 1-(2-desoxi-2,2-difluoro-D-ribofuranosil)-4-aminopiridin-2-ona clorhidratode gemcitabina de fórmula (I), separando los grupos benzoilo de bloqueo de compuestos debeta-1-(2-desoxi-2,2-difluoro-3,5-di-O-benzoil-D-ribofuranosil)-4- aminopirimidina-2-ona en presencia de cantidades catalíticas de alquilaminas,enun medio solvente de metanol o etanol, bajo exclusión de agua. El clorhidrato gemcitabina se recuperatratando la solución formada con ácido clorhídrico y unantisolvente.
AR33407495A 1994-12-13 1995-11-01 Procedimiento para preparar clorhidrato de 1-(2'-desoxi-2'2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona AR001041A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/355,372 US5637688A (en) 1994-12-13 1994-12-13 Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Publications (1)

Publication Number Publication Date
AR001041A1 true AR001041A1 (es) 1997-09-24

Family

ID=23397211

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33407495A AR001041A1 (es) 1994-12-13 1995-11-01 Procedimiento para preparar clorhidrato de 1-(2'-desoxi-2'2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona

Country Status (31)

Country Link
US (2) US5637688A (es)
EP (1) EP0719788B1 (es)
JP (1) JPH10510806A (es)
KR (1) KR100424991B1 (es)
CN (1) CN1047177C (es)
AR (1) AR001041A1 (es)
AT (1) ATE179986T1 (es)
AU (1) AU689674B2 (es)
BG (1) BG62738B1 (es)
BR (1) BR9509979A (es)
CO (1) CO4520286A1 (es)
CZ (1) CZ290941B6 (es)
DE (1) DE69509624T2 (es)
DK (1) DK0719788T3 (es)
ES (1) ES2130542T3 (es)
GR (1) GR3030265T3 (es)
HU (1) HU219021B (es)
IL (1) IL115852A (es)
MY (1) MY112488A (es)
NO (1) NO306783B1 (es)
NZ (1) NZ296476A (es)
PE (1) PE49296A1 (es)
PL (1) PL181732B1 (es)
RO (1) RO117327B1 (es)
RU (1) RU2154648C2 (es)
SI (1) SI0719788T1 (es)
TW (1) TW379226B (es)
UA (1) UA48152C2 (es)
WO (1) WO1996018637A1 (es)
YU (1) YU49314B (es)
ZA (1) ZA959320B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
EP0870506A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
PT1041985E (pt) * 1997-12-22 2006-07-31 Schering Corp Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas
US6376470B1 (en) 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
WO2002028387A1 (en) * 2000-10-03 2002-04-11 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
WO2005014010A1 (en) * 2003-07-24 2005-02-17 Eli Lilly And Company Pharmaceutical composition comprising gemcitabine and cyclodextrines
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
CN101076536A (zh) * 2004-07-30 2007-11-21 药华医药股份有限公司 β-核苷的立体选择性合成
WO2006070985A1 (en) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
DE602005019626D1 (de) * 2005-03-04 2010-04-08 Fresenius Kabi Oncology Ltd Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'-difluor-d-ribufuranosylnukleosiden
WO2006095359A1 (en) * 2005-03-10 2006-09-14 Sms Pharmaceuticals Limited Synthesis of 2-deoxy-2, 2-di fluoro-d-ribo furanose-3, 5 di(4-methy/4-nitro-chloro)benzoate and its conversion to gemcitabine hydrochloride thereof
WO2006119347A1 (en) * 2005-05-02 2006-11-09 Pharmaessentia Corp. STEREOSELECTIVE SYNTHESIS OF β-NUCLEOSIDES
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’,2’-二氟-胞苷合成的方法
WO2007049294A1 (en) * 2005-10-28 2007-05-03 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride.
KR101259637B1 (ko) * 2005-12-14 2013-04-30 주식회사종근당 1-(2´-데옥시-2´,2´-디플루오로-디-리보푸라노실)-4-아미노피리미딘-2-온또는 그의 염산염의 제조방법
RU2345087C2 (ru) * 2006-02-06 2009-01-27 Др. Редди`С Лабораторис Лтд. Способ получения и очистки гемцитабина гидрохлорида
WO2008045419A1 (en) * 2006-10-10 2008-04-17 Pharmasset, Inc. Preparation of nucleosides ribofuranosyl pyrimidines
US20090069354A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched gemcitabine
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
KR20100102107A (ko) * 2007-11-06 2010-09-20 파마이센시아 코퍼레이션 β-뉴클레오시드의 새로운 합성 방법
IT1393062B1 (it) * 2008-10-23 2012-04-11 Prime Europ Therapeuticals Procedimento per la preparazione di gemcitabina cloridrato
UY32546A (es) * 2009-04-06 2010-10-29 Eisai Inc Composiciones y metodos para tratar cancer
EP2416781B1 (en) * 2009-04-06 2017-03-08 Otsuka Pharmaceutical Co., Ltd. Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
TWI477508B (zh) * 2009-04-06 2015-03-21 Otsuka Pharma Co Ltd 用以治療癌症之組成物及方法
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
EP2431376B2 (en) * 2009-05-15 2024-02-07 Delta-Fly Pharma, Inc. Novel stable crystal of 1-(2'-cyano-2'-deoxy-beta -d-arabinofuranosyl)cytosine monohydrochloride
CN101628927B (zh) * 2009-08-07 2012-10-10 卡硼瑞(北京)科技有限公司 以1,3,5-三-O-苯甲酰基-α-D-呋喃核糖为原料立体选择性制备β-二氟胞苷盐酸盐的方法
CN102453064B (zh) * 2011-06-30 2014-07-09 江苏豪森药业股份有限公司 制备吉西他滨盐酸盐的方法
CN102659884B (zh) * 2012-04-23 2014-07-02 南京臣功制药股份有限公司 盐酸吉西他滨的提纯方法
CN103224541B (zh) * 2013-04-27 2015-07-01 江苏豪森药业股份有限公司 吉西他滨α-异构体转化回收工艺
CN104402945A (zh) * 2014-11-27 2015-03-11 苏州乔纳森新材料科技有限公司 一种3-脱氧-1,2-o-异丙叉-d-呋喃木糖的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817978A (en) * 1971-06-16 1974-06-18 Syntex Inc 4-fluoro nucleosides and sugar intermediates, and methods of preparing
JPS5924999B2 (ja) * 1978-06-10 1984-06-13 富山化学工業株式会社 新規な5−フルオロ−2′−デオキシ−β−ウリジン誘導体の製造法
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
BR9302431A (pt) * 1992-06-22 1994-01-11 Lilly Co Eli Processo de glicosilacao de anion estereosseletivo
AU4134793A (en) * 1992-06-22 1993-12-23 Eli Lilly And Company 2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
CA2105112C (en) * 1992-09-01 2005-08-02 Thomas C. Britton A process for anomerizing nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride

Also Published As

Publication number Publication date
WO1996018637A1 (en) 1996-06-20
CZ179897A3 (en) 1997-09-17
BR9509979A (pt) 1998-06-09
AU4110196A (en) 1996-07-03
JPH10510806A (ja) 1998-10-20
EP0719788B1 (en) 1999-05-12
UA48152C2 (uk) 2002-08-15
IL115852A (en) 1999-09-22
SI0719788T1 (en) 1999-10-31
US5637688A (en) 1997-06-10
DE69509624D1 (de) 1999-06-17
CN1047177C (zh) 1999-12-08
ATE179986T1 (de) 1999-05-15
BG62738B1 (bg) 2000-06-30
PE49296A1 (es) 1996-11-21
CZ290941B6 (cs) 2002-11-13
KR100424991B1 (ko) 2004-05-20
HU219021B (hu) 2001-01-29
NO972679D0 (no) 1997-06-11
ES2130542T3 (es) 1999-07-01
AU689674B2 (en) 1998-04-02
NO306783B1 (no) 1999-12-20
NO972679L (no) 1997-06-11
RO117327B1 (ro) 2002-01-30
DK0719788T3 (da) 1999-11-01
MY112488A (en) 2001-06-30
GR3030265T3 (en) 1999-08-31
EP0719788A3 (en) 1996-09-25
YU49314B (sh) 2005-06-10
PL181732B1 (en) 2001-09-28
DE69509624T2 (de) 1999-10-07
PL321046A1 (en) 1997-11-24
TW379226B (en) 2000-01-11
US5808048A (en) 1998-09-15
ZA959320B (en) 1997-05-05
NZ296476A (en) 1998-12-23
IL115852A0 (en) 1996-01-31
CO4520286A1 (es) 1997-10-15
RU2154648C2 (ru) 2000-08-20
EP0719788A2 (en) 1996-07-03
YU70895A (sh) 1998-09-18
CN1169728A (zh) 1998-01-07
MX9704322A (es) 1997-09-30
BG101591A (en) 1998-03-31
HUT77929A (hu) 1998-11-30

Similar Documents

Publication Publication Date Title
ATE67768T1 (de) Nukleosid-derivate und ihre verwendung in der oligonukleosid-synthese.
ES514080A0 (es) Procedimiento para estabilizar polimeros contra la degradacion por radiacion ultravioleta.
ES8802227A1 (es) Procedimiento de obtencion de derivados de mitomicina.
FI965140A0 (fi) Tulehdussytokiinien inhibiitteinä hyödylliset hydroksialkyyliammoniumpyrimidiinit tai puriinit ja nukleosidijohdannaiset
ES2194853T3 (es) Tinta, metodo de impresion por chorros de tinta e instrumento que los utiliza.
ES8304096A1 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES2098266T3 (es) Un metodo para hacer un nucleosido, su uso y metodo para hacer una composicion farmaceutica con el mismo.
ATE148501T1 (de) Durch aromaten substituiertes glykosid
RU97111801A (ru) Способ получения 1-(2'-деокси-2',2'-дифтор-d-рибофуранозил)-аминопиримидин-2-он гидрохлорида
ES2078454T3 (es) Procedimiento de tratamiento de un sustrato poroso.
BR0005005A (pt) Aditivo de polìmero para um meio de banho alcalino de eletrogalvanização de zinco ou liga de zinco, meio de banho alcalino de zinco ou liga de zinco, processo para eletrogalvanizar zinco e/ou ligas de zinco em um substrato condutivo, e uso do polìmero
ES8706608A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
AR245695A1 (es) Procedimiento de preparacion del 5,6-dihidroxiindol o de su derivado 3-alquilado,intermediarios utilizados en dicho procedimiento y procedimiento para preparar dichos intermediarios.
KR840005076A (ko) A-21978c 사이클릭펩티드 유도체의 제조방법
RU94002329A (ru) Модифицированные олигодезоксирибонуклеотиды, композиция, способ лечения и промежуточные соединения
CO4410198A1 (es) Forma fisica de un derivado de dihidro-2,3-benzodiacepina
ES8302021A1 (es) Procedimiento para la preparacion de 3-0-desmenlistamicina b.
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
ES8609353A1 (es) Procedimiento para la obtencion de un derivado del azucar
ES2043072T3 (es) Procedimiento para la diacilacion de compuestos que comprenden dos nucleos aromaticos.
SE8206548D0 (sv) Bensylidenderivat
ES2005153A6 (es) Procedimiento para el funcionalizado de yodo-polifluoralcanos por reduccion electroquimica.
ES8204990A1 (es) Procedimiento para preparar sal de (dl)-lisina de 2-(alfa- teoniltio)-tiopropionil-glicina
ES2110700T3 (es) Procedimiento para la preparacion de compuestos de cloruro de acido.
ES2156505B1 (es) Procedimiento para la obtencion de derivados de arilalcoxicarbonillo.